Cargando…
N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease
BACKGROUND: Normal human tissues do not express glycans terminating with the sialic acid N-glycolylneuraminic acid (Neu5Gc), yet Neu5Gc-containing glycans have been consistently found in human tumor tissues, cells and secretions and have been proposed as a cancer biomarker. We engineered a Neu5Gc-sp...
Autores principales: | Shewell, Lucy K., Day, Christopher J., Kutasovic, Jamie R., Abrahams, Jodie L., Wang, Jing, Poole, Jessica, Niland, Colleen, Ferguson, Kaltin, Saunus, Jodi M., Lakhani, Sunil R., von Itzstein, Mark, Paton, James C., Paton, Adrienne W., Jennings, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962556/ https://www.ncbi.nlm.nih.gov/pubmed/35346112 http://dx.doi.org/10.1186/s12885-022-09428-0 |
Ejemplares similares
-
N-glycolylneuraminic acid as a carbohydrate cancer biomarker
por: Wang, Jing, et al.
Publicado: (2023) -
Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study
por: Kutasovic, Jamie R, et al.
Publicado: (2018) -
Landscape of Epidermal Growth Factor Receptor Heterodimers in Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2022) -
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019) -
Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1
por: Kalaw, Emarene, et al.
Publicado: (2020)